The Key, The Spark, The Biosphere and The Catalyst at Newcastle Helix Three of Newcastle Helix's landmark buildings are helping to shape the future of smart building management as part of a major European research and development project. The Core, The Spark and the Urban Sciences Building are now entering the testing phase of Project WILSON, a Horizon Europe EU-funded initiative bringing together businesses, universities and research organisations from across Europe to devel

Data with Real-World Impact For Esther Murphy, CEO & Co-founder at Jumping Rivers, the most exciting projects are those that create meaningful impact, whether that's improving business processes, increasing efficiencies or delivering health and environmental benefits. One example is the team's work with the water industry, helping organisations make sense of vast amounts of time-series data collected from multiple sources across regions and across the country. The challenge i

Iksuda Therapeutics, a Newcastle Helix-based biotechnology company has reached a key step in the journey from laboratory research to patient care. Iksuda Therapeutics has received clearance from the US Food and Drug Administration (FDA) to begin human clinical trials of IKS04, a new cancer treatment being developed for gastrointestinal cancers, including colorectal, gastric and pancreatic cancers. The clearance follows approval of the company's Investigational New Drug (IND)